Patent intelligence · WO
WO 2005092872
INHIBITEURS DE PEPTIDE DEFORMYLASE
INHIBITEURS DE PEPTIDE DEFORMYLASE
Patent details — WO 2005092872
- Jurisdiction
- WO
- Status
- expired
- Grant date
- Oct 6, 2005
- Expiration
- Oct 1, 2025
- Applicant
- ARPIDA AS [DK]
- CPC classes
- A61K31/5415, A61P/3100, A61P/3104, A61P31/00
Quick answer
WO 2005092872 (INHIBITEURS DE PEPTIDE DEFORMYLASE) is held by ARPIDA AS [DK]. Status: expired. Granted Oct 6, 2005. Expires Oct 1, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ARPIDA AS [DK]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K31/5415, A61P/3100, A61P/3104, A61P31/00
More from ARPIDA AS [DK]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2005092872?
WO 2005092872 (INHIBITEURS DE PEPTIDE DEFORMYLASE) is held by ARPIDA AS [DK]. Status: expired. Granted Oct 6, 2005. Expires Oct 1, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2005092872?
ARPIDA AS [DK] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does WO 2005092872 expire?
Our index shows an expiration date of Oct 1, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.